Anti-Coagulant Slows Down Tumor Growth And Spread
10/28/2011
According to a new study led by Dr Camille Ettelaie of the University of Hull and Dr Anthony Maraveyas, consultant oncologist from Hull's Castle Hill Hospital, anti-coagulants known collectively as Low Molecular Weight Heparin (LMWH), that are given routinely to individuals with cancer in order to treat or lower the risk of thrombosis, might restrain the growth and spread of tumors as well...
Abbott's Genetic Test For Acute Myeloid Leukemia Prognosis Cleared By FDA
10/28/2011
Abbott (NYSE: ABT) announced it has received 510(k) clearance from the U.S. Food and Drug Administration for a new in vitro diagnostic test to aid in determining the prognosis of patients with acute myeloid leukemia (AML), one of the most common types of leukemia in older adults...
HPV For Boys Doesn't Solve Problem, Says Association Of American Physicians And Surgeons
10/28/2011
The CDC has added still another vaccine to the recommended list: three doses of human papillomavirus (HPV) vaccine (Gardasil) for boys age 11-12. HPV causes genital warts, and four of about 100 strains have been linked to cancer, especially cervical cancer in women...
Preclinical Testing Shows Improved Effectiveness Of New Oncolytic Virus
10/28/2011
A new fourth-generation oncolytic virus designed to both kill cancer cells and inhibit blood-vessel growth has shown greater effectiveness than earlier versions when tested in animal models of human brain cancer. Researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J...
Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") announced that the U.S. Food and Drug Administration (FDA) has granted Alberto J. Montero, M.D...
Compound Found In Common Wart Treatment Shows Promise As Leukemia Therapy
10/28/2011
A new potential leukemia therapy targets only cancer cells, while leaving healthy cells alone. Many current chemotherapy treatments affect cancer cells and healthy cells, causing significant side effects, such as fatigue, hair loss, nausea, anxiety and depression...
Abbott's Genetic Test For Acute Myeloid Leukemia Prognosis Cleared By FDA
10/28/2011
Abbott (NYSE: ABT) announced it has received 510(k) clearance from the U.S. Food and Drug Administration for a new in vitro diagnostic test to aid in determining the prognosis of patients with acute myeloid leukemia (AML), one of the most common types of leukemia in older adults...
HPV For Boys Doesn't Solve Problem, Says Association Of American Physicians And Surgeons
10/28/2011
The CDC has added still another vaccine to the recommended list: three doses of human papillomavirus (HPV) vaccine (Gardasil) for boys age 11-12. HPV causes genital warts, and four of about 100 strains have been linked to cancer, especially cervical cancer in women...
Preclinical Testing Shows Improved Effectiveness Of New Oncolytic Virus
10/28/2011
A new fourth-generation oncolytic virus designed to both kill cancer cells and inhibit blood-vessel growth has shown greater effectiveness than earlier versions when tested in animal models of human brain cancer. Researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J...
Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") announced that the U.S. Food and Drug Administration (FDA) has granted Alberto J. Montero, M.D...